Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Queensland Health
QuintilesIMS
Covington
Dow
Novartis
Fuji
Federal Trade Commission
Citi
Express Scripts

Generated: January 16, 2018

DrugPatentWatch Database Preview

Phenazopyridine hydrochloride; sulfamethoxazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phenazopyridine hydrochloride; sulfamethoxazole and what is the scope of phenazopyridine hydrochloride; sulfamethoxazole freedom to operate?

Phenazopyridine hydrochloride; sulfamethoxazole
is the generic ingredient in two branded drugs marketed by Roche and Able, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for phenazopyridine hydrochloride; sulfamethoxazole.
Summary for phenazopyridine hydrochloride; sulfamethoxazole

US Patents and Regulatory Information for phenazopyridine hydrochloride; sulfamethoxazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Able SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim TABLET;ORAL 021105-001 Jun 26, 2001 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche AZO GANTANOL phenazopyridine hydrochloride; sulfamethoxazole TABLET;ORAL 013294-001 Sep 10, 1987 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Dow
UBS
Harvard Business School
Fuji
Chinese Patent Office
Baxter
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot